Lanean...
Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK
INTRODUCTION: Patients with type 2 diabetes mellitus (T2DM) who fail to meet glycaemic control are at increased risk of diabetes complications. For patients who cannot maintain glycaemic control with oral medication, one recommended option is to add an injectable glucagon-like peptide-1 receptor ago...
Gorde:
| Argitaratua izan da: | Drugs R D |
|---|---|
| Egile Nagusiak: | , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer International Publishing
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6544605/ https://ncbi.nlm.nih.gov/pubmed/31115873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-019-0273-0 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|